Dosed delivery of autonomic modulation therapy
US9517350B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2014 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Dec 2, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3727
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.